Hover over the bar plot to get the GO term. Differentially targeted genes and TFs were computed by comparing a cancer network to all other cancers.
Tool description
PANDA reconstructs a gene regulatory network using TF PPI, TF DNA binding motif, and gene expression samples.
You can check the phenotypic information for the clinical variables of the samples that were used to reconstruct the network.
The variable Samples indicates the number of samples used for network reconstruction. For single-sample networks, clicking the number of samples links to the phenotypic variable table and the individual
networks. The number in the Sample variable and the phenotypic variable table may be different because the table can include samples from other studies. For example, in colon cancer, 444 TCGA samples were
used to build LIONESS networks in a first study and 445 samples were used for a more recent study. The superset of both TCGA samples is comprised of 487 samples, which is the size of the pheotypic variables
table. This discrepancy is due to different pre-processinng techniques, inclusion/exclusion criteria, and sample quality-control.
# | Tissue | Tool | netZoo release | Network |
PPI |
Motif | Expression | Regulator | nReg | Genes | Data | Samples | Precision |
Reference |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Uveal Melanoma | PANDA | netZooR 0.9 | TF | 644 | 29375 | TCGA | 80 | D |
Variable description
This is a description of the primary clinical variables of the gene expression samples that were used to generate the gene regulatory network.
Sample |
Gender | Race | Stage |
Vital status | Age |
Days to last follow up | Tumor ID |
---|---|---|---|---|---|---|---|
TCGA-V4-A9EF-01A | MALE | WHITE | Stage IIIB | Alive | 56 | 719 | UVM |
TCGA-YZ-A983-01A | FEMALE | WHITE | Stage IIB | Alive | 51 | 154 | UVM |
TCGA-V4-A9EK-01A | FEMALE | WHITE | Stage IIB | Alive | 37 | 567 | UVM |
TCGA-VD-AA8N-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 86 | 44 | UVM |
TCGA-V4-A9EI-01A | MALE | WHITE | Stage IIIB | Dead | 78 | [Not Available] | UVM |
TCGA-VD-A8KL-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 77 | 3 | UVM |
TCGA-VD-A8KM-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 65 | 4 | UVM |
TCGA-V4-A9EA-01A | MALE | WHITE | Stage IIIA | Alive | 66 | 751 | UVM |
TCGA-V4-A9E5-01A | FEMALE | WHITE | Stage IIIB | Alive | 51 | 1906 | UVM |
TCGA-WC-A885-01A | MALE | WHITE | Stage IIA | Alive | 60 | 315 | UVM |
TCGA-VD-AA8O-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 77 | 228 | UVM |
TCGA-VD-A8K8-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 56 | 20 | UVM |
TCGA-YZ-A982-01A | FEMALE | WHITE | Stage IIIB | Alive | 79 | 159 | UVM |
TCGA-VD-A8KK-01A | MALE | [Not Evaluated] | Stage IIIA | Alive | 54 | 3 | UVM |
TCGA-V4-A9EE-01A | MALE | WHITE | Stage IIB | Dead | 86 | [Not Available] | UVM |
TCGA-V4-A9E7-01A | MALE | WHITE | Stage IIIA | Dead | 76 | [Not Available] | UVM |
TCGA-V4-A9EY-01A | FEMALE | WHITE | Stage IIIA | Alive | 66 | 405 | UVM |
TCGA-WC-A883-01A | FEMALE | WHITE | Stage IIIA | Dead | 76 | [Not Available] | UVM |
TCGA-V4-A9EQ-01A | MALE | WHITE | Stage IIIA | Dead | 64 | [Not Available] | UVM |
TCGA-V3-A9ZY-01A | MALE | WHITE | Stage IIB | Alive | 54 | 123 | UVM |
TCGA-VD-A8KA-01B | MALE | [Not Evaluated] | Stage IIB | Alive | 22 | 842 | UVM |
TCGA-V4-A9EU-01A | FEMALE | WHITE | Stage IIIC | Alive | 83 | 709 | UVM |
TCGA-V4-A9EM-01A | MALE | WHITE | Stage IIIA | Alive | 53 | 488 | UVM |
TCGA-VD-A8KI-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 68 | 38 | UVM |
TCGA-V4-A9EL-01A | MALE | WHITE | Stage IIIA | Alive | 60 | 583 | UVM |
TCGA-V4-A9F2-01A | FEMALE | WHITE | Stage IIIA | Alive | 78 | 371 | UVM |
TCGA-V3-A9ZX-01A | MALE | WHITE | Stage IIB | Alive | 56 | 137 | UVM |
TCGA-V4-A9F8-01A | MALE | WHITE | Stage IIIA | Alive | 68 | 582 | UVM |
TCGA-V4-A9EH-01A | MALE | WHITE | Stage IIIB | Alive | 53 | 670 | UVM |
TCGA-V4-A9F0-01A | MALE | WHITE | Stage IIIB | Alive | 59 | 607 | UVM |
TCGA-V4-A9F3-01A | FEMALE | WHITE | Stage IIIA | Alive | 49 | 525 | UVM |
TCGA-VD-AA8M-01A | MALE | [Not Evaluated] | Stage IIA | Alive | 64 | 6 | UVM |
TCGA-WC-A88A-01A | MALE | WHITE | Stage IV | Dead | 75 | [Not Available] | UVM |
TCGA-VD-A8KF-01A | MALE | [Not Evaluated] | Stage IIIB | Dead | 68 | [Not Available] | UVM |
TCGA-VD-AA8S-01B | MALE | [Not Evaluated] | Stage IIA | Alive | 40 | 245 | UVM |
TCGA-WC-A87W-01A | FEMALE | WHITE | Stage IIA | Alive | 57 | 977 | UVM |
TCGA-V4-A9E9-01A | MALE | WHITE | Stage IIIA | Alive | 50 | 767 | UVM |
TCGA-VD-A8KB-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 66 | 660 | UVM |
TCGA-WC-A888-01A | MALE | WHITE | Stage IIB | Alive | 76 | 52 | UVM |
TCGA-V4-A9F5-01A | FEMALE | WHITE | Stage IV | Alive | 85 | 202 | UVM |
TCGA-VD-A8K9-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 71 | 14 | UVM |
TCGA-V4-A9ES-01A | FEMALE | WHITE | Stage IIIA | Alive | 54 | 1027 | UVM |
TCGA-WC-A87Y-01A | MALE | WHITE | [Not Available] | Alive | 59 | 369 | UVM |
TCGA-VD-AA8P-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 64 | 86 | UVM |
TCGA-V4-A9EV-01A | FEMALE | WHITE | Stage IIIA | Alive | 59 | 836 | UVM |
TCGA-YZ-A985-01A | FEMALE | WHITE | Stage IIIA | Alive | 41 | 599 | UVM |
TCGA-V4-A9ET-01A | MALE | WHITE | Stage IIIB | Alive | 57 | 872 | UVM |
TCGA-VD-A8KD-01A | MALE | [Not Evaluated] | Stage IV | Dead | 72 | [Not Available] | UVM |
TCGA-VD-A8KJ-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 53 | 961 | UVM |
TCGA-V4-A9EO-01A | MALE | WHITE | Stage IIIA | Alive | 74 | 407 | UVM |
TCGA-V4-A9F4-01A | MALE | WHITE | Stage IIIA | Alive | 41 | 256 | UVM |
TCGA-VD-AA8R-01A | FEMALE | [Not Evaluated] | Stage IIB | Alive | 78 | 2 | UVM |
TCGA-V4-A9F7-01A | FEMALE | WHITE | Stage IIB | Alive | 78 | 927 | UVM |
TCGA-WC-A881-01A | MALE | WHITE | Stage IIB | Alive | 75 | 694 | UVM |
TCGA-WC-A882-01A | FEMALE | WHITE | Stage IIB | Alive | 50 | 344 | UVM |
TCGA-WC-A880-01A | MALE | WHITE | Stage IIIA | Alive | 63 | 842 | UVM |
TCGA-WC-A87T-01A | MALE | WHITE | Stage IIB | Alive | 64 | 2149 | UVM |
TCGA-WC-AA9E-01A | MALE | WHITE | Stage IIA | Alive | 60 | 315 | UVM |
TCGA-VD-A8KG-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 47 | 19 | UVM |
TCGA-WC-AA9A-01A | FEMALE | WHITE | Stage IIA | Dead | 70 | [Not Available] | UVM |
TCGA-YZ-A980-01A | MALE | WHITE | Stage IIIA | Alive | 75 | 1283 | UVM |
TCGA-VD-A8KN-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 60 | 7 | UVM |
TCGA-VD-A8KO-01A | MALE | [Not Evaluated] | Stage IIA | Alive | 51 | 26 | UVM |
TCGA-VD-A8KH-01A | MALE | [Not Evaluated] | Stage IIIB | Alive | 69 | 10 | UVM |
TCGA-V4-A9EW-01A | FEMALE | WHITE | Stage IIIA | Alive | 44 | 774 | UVM |
TCGA-RZ-AB0B-01A | FEMALE | WHITE | Stage IV | Dead | 47 | [Not Available] | UVM |
TCGA-VD-A8KE-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 74 | 6 | UVM |
TCGA-V4-A9F1-01A | FEMALE | WHITE | Stage IIB | Alive | 46 | 556 | UVM |
TCGA-V4-A9EX-01A | FEMALE | WHITE | Stage IIIA | Dead | 55 | [Not Available] | UVM |
TCGA-YZ-A984-01A | FEMALE | WHITE | Stage IIB | Alive | 50 | 946 | UVM |
TCGA-VD-AA8T-01A | FEMALE | [Not Evaluated] | Stage IIA | Alive | 83 | 49 | UVM |
TCGA-V4-A9EJ-01A | MALE | WHITE | Stage IIB | Alive | 38 | 382 | UVM |
TCGA-VD-AA8Q-01A | MALE | [Not Evaluated] | Stage IIB | Alive | 71 | 2 | UVM |
TCGA-V4-A9EC-01A | FEMALE | WHITE | Stage IIB | Alive | 75 | 743 | UVM |
TCGA-VD-A8K7-01B | MALE | [Not Evaluated] | Stage IIIA | Alive | 39 | 3 | UVM |
TCGA-V4-A9EZ-01A | FEMALE | WHITE | Stage IIB | Alive | 78 | 599 | UVM |
TCGA-V4-A9E8-01A | MALE | WHITE | Stage IIIA | Dead | 49 | [Not Available] | UVM |
TCGA-V4-A9ED-01A | MALE | WHITE | Stage IIIA | Alive | 45 | 654 | UVM |
TCGA-WC-A87U-01A | MALE | WHITE | Stage IIIA | Dead | 73 | [Not Available] | UVM |
TCGA-WC-A884-01A | FEMALE | WHITE | Stage IIIB | Alive | 35 | 12 | UVM |
Sample | Gender | Race | Stage | Status | Age | Days to follow up | Tumor ID |